I agree. There was a risk of gap filling down towards 4 cents, but persistent buying seems to have won the day over the last few weeks, next test looks like up.
I had a look at all the substantial holdings across the junior Bio-tech sector, and no one has a register as good as ANP. Some high quality/smart money all over this one.
I still think an easy easy buy under 6 cents.
